- Report
- October 2022
- 150 Pages
Global
From €5717EUR$5,950USD£4,908GBP
- Report
- October 2023
- 90 Pages
India
From €3363EUR$3,500USD£2,887GBP
- Report
- June 2021
- 48 Pages
Global
- Report
- January 2022
- 200 Pages
Global
From €7206EUR$7,500USD£6,186GBP
- Drug Pipelines
- January 2019
- 60 Pages
Global
From €1922EUR$2,000USD£1,650GBP
- Report
- January 2023
- 159 Pages
Global
From €2402EUR$2,500USD£2,062GBP
- Report
- September 2022
- 115 Pages
Global
From €7206EUR$7,500USD£6,186GBP
- Report
- September 2022
- 62 Pages
Global
From €3795EUR$3,950USD£3,258GBP
- Report
- January 2022
- 60 Pages
Global
From €3795EUR$3,950USD£3,258GBP
- Report
- February 2022
- 167 Pages
Global
From €3060EUR$3,185USD£2,627GBP
€4372EUR$4,550USD£3,753GBP
- Report
- January 2022
- 115 Pages
Global
From €4564EUR$4,750USD£3,918GBP
- Report
- January 2022
- 121 Pages
Global
From €4564EUR$4,750USD£3,918GBP
- Report
- April 2023
- 120 Pages
Global
From €4564EUR$4,750USD£3,918GBP
- Report
- April 2023
- 120 Pages
Global
From €4564EUR$4,750USD£3,918GBP
- Report
- August 2020
- 85 Pages
North America
From €4564EUR$4,750USD£3,918GBP
- Report
- February 2020
- 44 Pages
Asia Pacific
From €3358EUR$3,495USD£2,883GBP
- Report
- June 2018
- 51 Pages
Global
From €3358EUR$3,495USD£2,883GBP
- Report
- July 2020
- 111 Pages
Asia Pacific
From €8643EUR$8,995USD£7,419GBP
- Clinical Trials
- January 2020
- 277 Pages
Global
From €2402EUR$2,500USD£2,062GBP
- Clinical Trials
- October 2019
- 318 Pages
Global
From €2402EUR$2,500USD£2,062GBP
The Stem Cell Transplant market is a subset of the larger stem cell industry. It involves the use of stem cells to treat a variety of diseases and conditions, including cancer, blood disorders, and genetic diseases. Stem cell transplants are used to replace damaged or diseased cells with healthy ones, and can be used to treat a variety of conditions.
The stem cell transplant market is a rapidly growing field, with new treatments and technologies being developed and tested. Companies in the market are focused on developing and commercializing stem cell therapies, as well as providing services related to stem cell transplantation. These companies include Celgene, Novartis, and Osiris Therapeutics. Additionally, there are a number of smaller companies that are focused on developing and commercializing stem cell therapies, such as Athersys, Inc., and Pluristem Therapeutics. Show Less Read more